06/11/2008
EU consultation on changes to pharmacovigilance
Source: DG Enterprise
The DG Enterprise wishes to consult stakeholders on changes to Eudralex Volume 9A "Pharmacovigilance for Medicinal Products for Human Use".
The Volume 9A Revision 2008 concerns additional guidance in Chapter I.7 on post-authorisation safety studies and clarifications in response to frequently asked questions, mainly regarding electronic reporting, in Chapters I.2, I.4, I.5 and Part III.
The changes to the text are in track changes in the document here
All comments should be sent to Ulla Närhi (ulla.narhi@ec.europa.eu ) by 2 January 2009 and the bellow emplate (word document) should be used for comments.
